Junaid A, Tang H, van Reeuwijk A, Abouleila Y, Wuelfroth P, van Duinen V, Stam W, van Zonneveld AJ, Hankemeier T, and Mashagh A.
iScience. 2020 Jan 24; 23(1): 100765
Péter S, Navis G, de Borst MH, von Schacky C, van Orten-Luiten AB, Zhernakova A, Witkamp RF, Janse A, Weber P, Bakker SJL, Eggersdorfer M.
iScience. 2020 Jan 24; 23(1): 100765
Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee DE, et al.
Eur J Prev Cardiol . 2019 May;26(8):824-835. doi: 10.1177/2047487318825350. Epub 2019 Feb 10.
Vermeulen RCH, Schymanski EL, Barabási AL, Miller GW.
Science 24 Jan 2020: Vol. 367, Issue 6476, pp. 392-396. DOI: 10.1126/science.aay3164
den Braver NR, Kok JG, Mackenbach JD, Rutter H, Oppert J-M, Compernolle S, Twisk JWR, Brug J, Beulens JWJ, Lakerveld, J.
International Journal of Behavioral Nutrition and Physical Activity volume 17, Article number: 8 (2020)
We know far less about the exposome than we do about the human genome. So far, we only understand about half of the disease burden for which we know the environment plays a role. If we want to prevent people from becoming ill, then we need to understand the other half too. We therefore want to systematically analyse the exposome for the first time. We will start with research into the causes of cardiovascular disease and type 2 diabetes. The techniques and insights from this research will also be applicable to other chronic conditions.
Read More
